← Back to Search

Mindfulness Based Relapse Prevention - Smoking and Alcohol for Tobacco Use

N/A
Waitlist Available
Led By Christine Vinci, PhD
Research Sponsored by H. Lee Moffitt Cancer Center and Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 20 weeks
Awards & highlights

Study Summary

This trial is testing a new treatment to help people reduce their alcohol use and quit smoking.

Eligible Conditions
  • Tobacco Use
  • Alcohol Use Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~20 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 20 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Aim 2: Number of Participants Scoring >3
Aim 2: Participant Retention
Aim 2: Percentage of Participants That Completed Questionnaires
+1 more
Secondary outcome measures
Aim 3: Percent of Heavy Alcohol Use at End of Treatment
Aim 3: Percent of Smoking Abstinence End of Treatment
Aim 3: Percent of Smoking Abstinence at 16 Week Follow-up
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Mindfulness Based Relapse PreventionExperimental Treatment1 Intervention
Participants will receive Mindfulness Based Relapse Prevention (MBRP), an existing substance use treatment, which has been modified to focus explicitly on smoking cessation and reduced alcohol use, creating Mindfulness Based Relapse Prevention - Smoking and Alcohol (MBRP-SA).
Group II: Cognitive Behavioral TherapyActive Control1 Intervention
Participants will receive Cognitive Behavioral Therapy (CBT) a well-established and commonly used treatment for substance abuse behaviors that utilizes problem solving and coping skills.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness Based Relapse Prevention - Smoking and Alcohol
2019
N/A
~70

Find a Location

Who is running the clinical trial?

National Institutes of Health (NIH)NIH
2,698 Previous Clinical Trials
7,492,432 Total Patients Enrolled
8 Trials studying Tobacco Use
8,399 Patients Enrolled for Tobacco Use
H. Lee Moffitt Cancer Center and Research InstituteLead Sponsor
543 Previous Clinical Trials
135,428 Total Patients Enrolled
2 Trials studying Tobacco Use
223 Patients Enrolled for Tobacco Use
National Center for Complementary and Integrative Health (NCCIH)NIH
832 Previous Clinical Trials
668,867 Total Patients Enrolled
1 Trials studying Tobacco Use
121 Patients Enrolled for Tobacco Use

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the recruitment phase of this trial still open to potential participants?

"As of this moment, clinicaltrials.gov lists this trial as no longer searching for patients - the first post date was January 14th 2019 with a final update on November 1st 2022. However, prospective participants are encouraged to look into 300 separate trials that remain open and actively recruiting individuals."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Development of a Mindfulness-Based Treatment for the Reduction of Alcohol Use and Smoking Cessation
2019. "Development of a Mindfulness-Based Treatment for the Reduction of Alcohol Use and Smoking Cessation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03734666.
~11 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top